Regulatory Focus |
Researchers Link FDA Actions to Decrease in LABA Use in Asthma Treatment
Regulatory Focus A recent study finds an association between regulatory actions by the US Food and Drug Administration (FDA) and the use of long-acting ?2-agonists (LABA) commonly used to treat asthma. The study, published in the Journal of Allergy and Clinical … Simple asthma screening test could improve care for children |
View full post on asthma – Google News